Dormant Company Accounts - COPIFAX LIMITED

Dormant Company Accounts - COPIFAX LIMITED


Companies House true 2021-04-01 2022-03-31 false 02539673 uk-bus:Director1 2021-04-01 2022-03-31 02539673 uk-bus:Director2 2021-04-01 2022-03-31 02539673 2021-04-01 2022-03-31 02539673 2022-03-31 02539673 uk-bus:EntityHasNeverTraded 2021-04-01 2022-03-31 02539673 uk-bus:FRS102 2021-04-01 2022-03-31 02539673 uk-bus:FullAccounts 2021-04-01 2022-03-31 02539673 uk-bus:AuditExempt-NoAccountantsReport 2021-04-01 2022-03-31 02539673 2021-03-31 02539673 uk-bus:OrdinaryShareClass1 2021-04-01 2022-03-31 02539673 uk-bus:OrdinaryShareClass2 2021-04-01 2022-03-31 02539673 uk-bus:OrdinaryShareClass3 2021-04-01 2022-03-31 02539673 uk-bus:PreferenceShareClass1 2021-04-01 2022-03-31 02539673 uk-bus:PreferenceShareClass2 2021-04-01 2022-03-31 02539673 uk-bus:PreferenceShareClass3 2021-04-01 2022-03-31 02539673 uk-core:ShareCapitalPreferenceShares 2022-03-31 02539673 uk-core:ShareCapitalPreferenceShares 2021-03-31 iso4217:GBP xbrli:shares

Registered Number 02539673

COPIFAX LIMITED

Dormant Accounts

31 March 2022

COPIFAX LIMITED Registered Number 02539673

Balance Sheet as at 31 March 2022

2022 2021
£ £
Called up share capital not paid
50000
50000
Net assets
50000
50000
Issued share capital
29000 A Ordinary Shares of £ 1 each 29000 29000
11000 B Ordinary Shares of £ 1 each 11000 11000
10000 C Ordinary Shares of £ 1 each 10000 10000
Total Shareholder funds
50000
50000

STATEMENTS

  1. For the year ending 31 March 2022 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 19 December 2022

And signed on their behalf by:
Jon Giles, Director